1. Diabetes Therapy Podcast Collection: Language Matters in Diabetes

   • Sanjay Kalra
   • Partha Kar

   Commentary Open access 28 May 2021 Pages: 1769 - 1777

2. Bempedoic Acid: The New Kid on the Block for the Treatment of Dyslipidemia and LDL Cholesterol: A Narrative Review

   • Uazman Alam
   • Dalal Y. Al-Bazz
   • Handrean Soran

   Review Open access 26 May 2021 Pages: 1779 - 1789

3. The Role of Finerenone in the Management of Diabetic Nephropathy

   • Stavroula Veneti
   • Konstantinos Tziomalos

   Review Open access 29 May 2021 Pages: 1791 - 1797

4. Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study)

   • Jan Brož
   • Denisa Janíčková Žďárská
   • Milan Kvapil

   Original Research Open access 24 May 2021 Pages: 1799 - 1808

   

5. Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications

   • Michael Joubert
   • Laurent Meyer
   • Yves Reznik

   Original Research Open access 24 May 2021 Pages: 1809 - 1820

   

6. The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective

   • Heather Gelhorn
   • Zaneta Balantac
   • Kristina S. Boye

   Original Research Open access 27 May 2021 Pages: 1821 - 1837

   

7. Review of Self-Reported Data from UK Do-It-Yourself Artificial Pancreas System (DIYAPS) Users to Determine Whether Demographic of Population Affects Use or Outcomes

   • Tim J. Street

   Original Research Open access 28 May 2021 Pages: 1839 - 1848

   

8. Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study

   • Shuhei Nakanishi
   • Masashi Shimoda
   • Hideaki Kaneto

   Original Research Open access 28 May 2021 Pages: 1849 - 1860

9. Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus

   • Xiaoling Cai
   • Linong Ji

   Original Research Open access 28 May 2021 Pages: 1861 - 1870

   

10. Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type 2 Diabetes

    • Ashkan Dehghani Zahedani
    • Solmaz Shariat Torbaghan
    • Michael P. Snyder

    Original Research Open access 28 May 2021 Pages: 1871 - 1886

    

11. A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients

    • Yingying Luo
    • Hong Wu
    • Linong Ji

    Original Research Open access 29 May 2021 Pages: 1887 - 1899

    

12. Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis

    • Jane L. Tarry-Adkins
    • Imogen D. Grant
    • Catherine E. Aiken

    Original Research Open access 02 June 2021 Pages: 1901 - 1914

    

13. Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation

    • Tine A. Bækdal
    • Astrid Breitschaft
    • Jeanett Borregaard

    Original Research Open access 02 June 2021 Pages: 1915 - 1927

    

14. The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

    • Luis-Emilio García-Pérez
    • Kristina S. Boye
    • Hélène Sapin

    Original Research Open access 07 June 2021 Pages: 1929 - 1946

    

15. Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand

    • Chaicharn Deerochanawong
    • Kriengsak Vareesangthip
    • Unchalee Permsuwan

    Original Research Open access 09 June 2021 Pages: 1947 - 1963

    

16. Treatment Patterns, Effectiveness, and Satisfaction Among Patients with Type 2 Diabetes Treated with Insulin in Saudi Arabia: Results of the RIMODIS Study

    • Fatima Y. AlSlail
    • Yasser A. Akil

    Original Research Open access 11 June 2021 Pages: 1965 - 1978

    

17. Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study

    • Abdullah M. Alguwaihes

    Original Research Open access 12 June 2021 Pages: 1979 - 1992

18. Pill Counting in the Determination of Factors Affecting Medication Adherence in Patients with Type 2 Diabetes: A Retrospective Observational Study

    • Megumi Shiomi
    • Momoka Kurobuchi
    • Katsuya Otori

    Original Research Open access 13 June 2021 Pages: 1993 - 2005

    

19. Electronic Medical Record Risk Modeling of Cardiovascular Outcomes Among Patients with Type 2 Diabetes

    • Dongzhe Hong
    • Daniel Fort
    • Eboni G. Price-Haywood

    Original Research Open access 18 June 2021 Pages: 2007 - 2017

20. Improvements in Glycemic Control Achieved by Altering the t_max Setting in the iLet^® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial

    • Steven J. Russell
    • Courtney Balliro
    • Edward R. Damiano

    Original Research Open access 19 June 2021 Pages: 2019 - 2033

    

21. A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents

    • Hirotaka Watada
    • Yasushi Kawakita
    • Manabu Akazawa

    Original Research Open access 20 June 2021 Pages: 2035 - 2047

    

22. Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study

    • Milena Velojic-Golubovic
    • Vojislav Ciric
    • Djordje S. Popovic

    Original Research Open access 23 June 2021 Pages: 2049 - 2058

    

23. Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study

    • Marie-Christine Turnin
    • Pierre Gourdy
    • the Educ@dom Study Group

    Original Research Open access 23 June 2021 Pages: 2059 - 2075

    

24. Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019

    • Kristina S. Boye
    • Maureen J. Lage
    • Jay Patrick Bae

    Brief Report Open access 02 June 2021 Pages: 2077 - 2087

    

25. Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

    • David A. Price
    • Qianqian Deng
    • Stayce E. Beck

    Brief Report Open access 04 June 2021 Pages: 2089 - 2099

    

26. Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial

    • Gian Pio Sorice
    • Francesca Cinti
    • Andrea Giaccari

    Study Protocol Open access 26 May 2021 Pages: 2101 - 2113